Literature DB >> 7586551

False-positive and false-negative rates in meconium drug testing.

C Moore1, D Lewis, J Leikin.   

Abstract

To determine the number of false-negative results produced by inefficient extraction of drugs from meconium, three published procedures were compared by using previously confirmed positive and negative meconium specimens. The methods were not equivalent in their ability to extract drugs from the matrix. To determine the number of false positives reported by the use of screen-only (unconfirmed) results, 535 screen-positive meconium specimens were subjects to confirmation by gas chromatography-mass spectrometry. Fifty-seven percent of the samples were confirmed positive for one or more of the drugs under investigation, showing that a false-positive rate as high as 43% may exist when unconfirmed screening results are used.

Mesh:

Substances:

Year:  1995        PMID: 7586551

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  7 in total

1.  Substance use during pregnancy: time for policy to catch up with research.

Authors:  Barry M Lester; Lynne Andreozzi; Lindsey Appiah
Journal:  Harm Reduct J       Date:  2004-04-20

2.  Development and validation of a liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry method for simultaneous analysis of 10 amphetamine-, methamphetamine- and 3,4-methylenedioxymethamphetamine-related (MDMA) analytes in human meconium.

Authors:  Tamsin Kelly; Teresa R Gray; Marilyn A Huestis
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-04-04       Impact factor: 3.205

3.  The authors reply.

Authors:  S Pichini; I Altieri; R Zuccaro; R Pacifici
Journal:  Clin Pharmacokinet       Date:  1996-07       Impact factor: 6.447

Review 4.  Bioanalytical procedures for monitoring in utero drug exposure.

Authors:  Teresa Gray; Marilyn Huestis
Journal:  Anal Bioanal Chem       Date:  2007-03-17       Impact factor: 4.142

5.  New meconium biomarkers of prenatal methamphetamine exposure increase identification of affected neonates.

Authors:  Teresa R Gray; Tamsin Kelly; Linda L LaGasse; Lynne M Smith; Chris Derauf; Penny Grant; Rizwan Shah; Amelia Arria; William Haning; Sheri Della Grotta; Arthur Strauss; Barry M Lester; Marilyn A Huestis
Journal:  Clin Chem       Date:  2010-02-25       Impact factor: 8.327

6.  Identification of prenatal amphetamines exposure by maternal interview and meconium toxicology in the Infant Development, Environment and Lifestyle (IDEAL) study.

Authors:  Teresa R Gray; Linda L LaGasse; Lynne M Smith; Chris Derauf; Penny Grant; Rizwan Shah; Amelia M Arria; Sheri A Della Grotta; Arthur Strauss; William F Haning; Barry M Lester; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2009-12       Impact factor: 3.681

7.  Novel biomarkers of prenatal methamphetamine exposure in human meconium.

Authors:  Teresa R Gray; Tamsin Kelly; Linda L LaGasse; Lynne M Smith; Chris Derauf; William Haning; Penny Grant; Rizwan Shah; Amelia Arria; Arthur Strauss; Barry M Lester; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2009-02       Impact factor: 3.681

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.